Stock Events

Stock Events

Lonza Group 

$80.90
213
-$0.92-1.12%Friday 20:59

Statistics

Day High
81.26
Day Low
80.5
52W High
82.63
52W Low
58.53
Volume
5,161
Avg. Volume
43,050
Mkt Cap
5.65B
P/E Ratio
45.11
Dividend Yield
0.39%
Dividend
0.32

Upcoming

Dividends

0.39%Dividend Yield
Jun 2026
$0.32
Jun 2026
$0.25
May 2025
$0.24
May 2025
$0.19
May 2024
$0.22
10Y Growth
N/A
5Y Growth
13.9%
3Y Growth
17.46%
1Y Growth
32.75%

Earnings

Jan 27Expected
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
Next
0
3.99
7.99
11.98
Expected EPS
11.324775
Actual EPS
N/A

Financials

-4.2%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
8.24BRevenue
-346.04MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LZAGY. It's not an investment recommendation.
Nestle SA
53
NESN.SW
Novartis
44
NOVN.SW
Microsoft
41
MSFT
Swiss Re
35
SREN.SW

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific offers similar biotechnology and pharmaceutical services, including contract manufacturing and development services, competing directly with Lonza's core business.
Danaher
DHR
Mkt Cap163.25B
Danaher Corporation, through its Life Sciences segment, competes in the bioprocessing space, offering products and services that overlap with Lonza's offerings in pharmaceutical development and manufacturing.
Charles River Laboratories International
CRL
Mkt Cap17.16B
Charles River Laboratories provides a range of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, competing with Lonza in contract development and manufacturing organization (CDMO) services.
IQVIA
IQV
Mkt Cap44.06B
IQVIA offers extensive clinical research services, including biopharmaceutical development, which competes with Lonza's services in drug development and manufacturing.
West Pharmaceutical Services
WST
Mkt Cap28.74B
West Pharmaceutical Services specializes in designing and manufacturing containment and delivery systems for injectable drugs and healthcare products, competing with Lonza in the pharmaceutical and biotech supply chain.
Bio-Rad Laboratories
BIO
Mkt Cap9.95B
Bio-Rad Laboratories offers products and services in life science research and clinical diagnostics, competing with Lonza in the provision of specialized instruments and reagents for the pharmaceutical industry.

About

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Show More
CEO
Wolfgang Wienand
Employees
16866
Country
Switzerland
ISIN
US54338V1017
WKN
000A0YF75

Listings

MI
IT
1LONN.MI
XETRA
DE
LO3.XETRA
MX
MX
LONNN.MX
MU
DE
LO3.MU

0 Comments

Share your thoughts

FAQs

What is Lonza Group stock price today?▼
The current price of LZAGY is $80.90 USD — it has decreased by -1.12% in the past 24 hours. Watch Lonza Group stock price performance more closely on the chart.
What is Lonza Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Lonza Group stocks are traded under the ticker LZAGY.
Is Lonza Group stock price growing?▼
LZAGY stock has risen by +3.76% compared to the previous week, the month change is a +18.53% rise, over the last year Lonza Group has showed a +22.15% increase.
What is Lonza Group market cap?▼
Today Lonza Group has the market capitalization of 5.65B
When is the next Lonza Group earnings date?▼
Lonza Group is going to release the next earnings report on January 27, 2027.
What were Lonza Group earnings last quarter?▼
LZAGY earnings for the last quarter are 10.09 USD per share, whereas the estimation was 10.76 USD resulting in a -6.19% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lonza Group revenue for the last year?▼
Lonza Group revenue for the last year amounts to 8.24B USD.
What is Lonza Group net income for the last year?▼
LZAGY net income for the last year is -346.04M USD.
Does Lonza Group pay dividends?▼
Yes, LZAGY dividends are paid annual. The last dividend per share was 0.25 . As of today, Dividend Yield (FWD)% is 0.39%.
How many employees does Lonza Group have?▼
As of November 8, 2026, the company has 16,866 employees.
In which sector is Lonza Group located?▼
Lonza Group operates in the Health & Wellness sector.
When did Lonza Group complete a stock split?▼
Lonza Group has not had any recent stock splits.
Where is Lonza Group headquartered?▼
Lonza Group is headquartered in Basel, Switzerland.